Axsome Therapeutics (AXSM) Net Income Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -8.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.63% |
| Dec 31, 2025 | 61.84% |
| Sep 30, 2025 | 26.89% |
| Jun 30, 2025 | 39.59% |
| Mar 31, 2025 | 13.08% |
| Dec 31, 2024 | 24.06% |
| Sep 30, 2024 | -3.86% |
| Jun 30, 2024 | -18.10% |
| Mar 31, 2024 | -508.27% |
| Dec 31, 2023 | -61.09% |
| Sep 30, 2023 | -38.77% |
| Jun 30, 2023 | -62.14% |
| Mar 31, 2023 | 71.64% |
| Dec 31, 2022 | -80.25% |
| Sep 30, 2022 | -28.50% |
| Jun 30, 2022 | -28.35% |
| Mar 31, 2022 | -35.45% |
| Dec 31, 2021 | -16.28% |
| Sep 30, 2021 | -60.91% |
| Jun 30, 2021 | -76.16% |
| Mar 31, 2021 | 9.93% |
| Dec 31, 2020 | -17.78% |
| Sep 30, 2020 | -12.47% |
| Jun 30, 2020 | -33.17% |
| Mar 31, 2020 | -205.29% |
| Dec 31, 2019 | -369.59% |
| Sep 30, 2019 | -132.31% |
| Jun 30, 2019 | -66.17% |
| Mar 31, 2019 | -42.28% |
| Dec 31, 2018 | 50.75% |
| Sep 30, 2018 | -234.66% |
| Jun 30, 2018 | -229.06% |
| Mar 31, 2018 | -201.76% |
| Dec 31, 2017 | -18.05% |
| Sep 30, 2017 | -14.68% |
| Jun 30, 2017 | -6.21% |
| Mar 31, 2017 | 24.56% |
| Dec 31, 2016 | 145.15% |
| Sep 30, 2016 | 314.05% |
| Jun 30, 2016 | 265.17% |
| Mar 31, 2016 | 226.98% |